Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EBIT (2018 - 2025)

Historic EBIT for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $61.7 million.

  • AdaptHealth's EBIT fell 276.75% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.8 million, marking a year-over-year increase of 60603.8%. This contributed to the annual value of $263.7 million for FY2024, which is 14407.28% up from last year.
  • As of Q3 2025, AdaptHealth's EBIT stood at $61.7 million, which was down 276.75% from $79.3 million recorded in Q2 2025.
  • Over the past 5 years, AdaptHealth's EBIT peaked at $97.7 million during Q4 2024, and registered a low of -$461.0 million during Q3 2023.
  • For the 5-year period, AdaptHealth's EBIT averaged around $12.9 million, with its median value being $52.9 million (2022).
  • Its EBIT has fluctuated over the past 5 years, first surged by 47100.84% in 2021, then crashed by 97071.71% in 2023.
  • Quarter analysis of 5 years shows AdaptHealth's EBIT stood at $69.1 million in 2021, then tumbled by 61.3% to $26.7 million in 2022, then plummeted by 914.77% to -$217.8 million in 2023, then soared by 144.84% to $97.7 million in 2024, then tumbled by 36.8% to $61.7 million in 2025.
  • Its EBIT stands at $61.7 million for Q3 2025, versus $79.3 million for Q2 2025 and $23.2 million for Q1 2025.